Anterix - ATEX Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Anterix in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" ATEX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ATEX, but not buy additional shares or sell existing shares.
View ATEX analyst ratings or view top-rated stocks.

1 brokers have issued 12 month price objectives for Anterix's stock. Their ATEX share price forecasts range from $42.00 to $42.00. On average, they anticipate the company's share price to reach $42.00 in the next twelve months. This suggests a possible upside of 49.3% from the stock's current price.
View analysts price targets for ATEX or view top-rated stocks among Wall Street analysts.

Anterix's stock was trading at $32.17 on January 1st, 2023. Since then, ATEX stock has decreased by 12.5% and is now trading at $28.14.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Friday, May 19th 2023.
View our ATEX earnings forecast.

Anterix Inc. (NASDAQ:ATEX) issued its quarterly earnings data on Wednesday, November, 3rd. The company reported ($0.67) EPS for the quarter, topping analysts' consensus estimates of ($0.68) by $0.01. The company earned $0.18 million during the quarter, compared to the consensus estimate of $0.18 million. Anterix had a negative net margin of 2,604.86% and a negative trailing twelve-month return on equity of 27.66%. During the same period last year, the firm posted ($0.94) EPS.

ETFs with the largest weight of Anterix (NASDAQ:ATEX) stock in their portfolio include SPDR S&P Telecom ETF (XTL), First Trust NASDAQ BuyWrite Income ETF (FTQI), ProShares Ultra Communication Services (LTL), Vanguard Communication Services ETF (VOX) and Fidelity MSCI Communication Services Index ETF (FCOM).Vanguard U.S. Minimum Volatility ETF (VFMV).

Based on aggregate information from My MarketBeat watchlists, some companies that other Anterix investors own include Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO), International Business Machines (IBM), Micron Technology (MU), Occidental Petroleum (OXY), Primo Water (PRMW), Stericycle (SRCL) and Applied Optoelectronics (AAOI).

Anterix trades on the NASDAQ under the ticker symbol "ATEX."

Anterix's stock is owned by a number of institutional and retail investors. Top institutional investors include Morgan Stanley (7.46%), Stonehill Capital Management LLC (4.61%), Geode Capital Management LLC (1.94%), Clearbridge Investments LLC (1.62%), Dimensional Fund Advisors LP (1.53%) and Roubaix Capital LLC (0.83%). Insiders that own company stock include Brian Mcauley, Christopher Guttman-Mccabe, Elaine Gangeri, Gena L Ashe, Hamid Akhavan, Leslie B Daniels, Leslie B Daniels, Morgan E Obrien, Owl Creek Asset Management, L, Robert Harris Schwartz, Ryan Gerbrandt, Thomas Clark Akers and Timothy Gray.
View institutional ownership trends.

Shares of ATEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ATEX stock can currently be purchased for approximately $28.14.

Anterix (NASDAQ:ATEX) has a market capitalization of $530.97 million and generates $1.65 million in revenue each year. The company earns $-37,520,000.00 in net income (profit) each year or ($2.29) on an earnings per share basis.

Anterix's mailing address is 3 GARRET MOUNTAIN PLAZA SUITE 401, WOODLAND PARK NJ, 07424. The official website for the company is www.anterix.com. The company can be reached via phone at (973) 771-0300, via email at nvecchiarelli@anterix.com, or via fax at 888-858-6245.